Published in Tissue Eng Part A on September 04, 2012
Adipose-derived stem cells promote angiogenesis and tissue formation for in vivo tissue engineering. Tissue Eng Part A (2013) 1.01
Trichostatin A enhances differentiation of human induced pluripotent stem cells to cardiogenic cells for cardiac tissue engineering. Stem Cells Transl Med (2013) 0.94
Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand? EMBO Mol Med (2015) 0.85
Pushing the envelope in tissue engineering: ex vivo production of thick vascularized cardiac extracellular matrix constructs. Tissue Eng Part A (2015) 0.78
Development of an Extracorporeal Perfusion Device for Small Animal Free Flaps. PLoS One (2016) 0.76
Trends in cardiovascular engineering: organizing the human heart. Trends Cardiovasc Med (2013) 0.75
Heart regeneration. Nature (2011) 5.91
A simple method for volumetry of organs in quantitative stereology. Mikroskopie (1970) 5.17
Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med (2006) 4.74
Tissue engineering of a differentiated cardiac muscle construct. Circ Res (2002) 4.50
Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci U S A (2009) 2.51
Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation (2000) 2.25
Pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique functionally integrates with the host heart, in vivo. Circ Res (2006) 2.02
Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng Part A (2010) 1.97
Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation (2008) 1.95
Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci U S A (2009) 1.91
Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J (2006) 1.90
Survival and function of bioengineered cardiac grafts. Circulation (1999) 1.72
Challenges in cardiac tissue engineering. Tissue Eng Part B Rev (2010) 1.66
Cardiac tissue engineering in an in vivo vascularized chamber. Circulation (2007) 1.48
Cardiac grafting of engineered heart tissue in syngenic rats. Circulation (2002) 1.43
An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct. FASEB J (2006) 1.30
Current status of cardiac transplantation and mechanical circulatory support. Curr Heart Fail Rep (2009) 1.05
Engineering cardiac tissue in vivo from human adipose-derived stem cells. Biomaterials (2010) 1.02
Omentopexy enhances graft function in myocardial cell sheet transplantation. Biochem Biophys Res Commun (2009) 0.94
Evaluation of a peritoneal-generated cardiac patch in a rat model of heterotopic heart transplantation. Cell Transplant (2009) 0.91
Development of a biological ventricular assist device: preliminary data from a small animal model. Circulation (2007) 0.87
Strategies in cardiac tissue engineering. ANZ J Surg (2010) 0.84
Heterotopic heart transplantation in rats: improved anesthetic and surgical technique. Transplant Proc (2010) 0.81
As originally published in 1993: right latissimus dorsi cardiomyoplasty augments left ventricular systolic performance. Updated in 2001. Ann Thorac Surg (2001) 0.78
NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair. Pharmacol Rev (2011) 2.53
Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice. Am J Physiol Heart Circ Physiol (2009) 2.00
The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle. Cardiovasc Res (2005) 1.72
Tissue-engineered breast reconstruction: bridging the gap toward large-volume tissue engineering in humans. Plast Reconstr Surg (2011) 1.63
NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells. Hypertension (2006) 1.61
Functional impairment after latissimus dorsi flap. ANZ J Surg (2009) 1.55
Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation (2005) 1.53
Cardiac tissue engineering in an in vivo vascularized chamber. Circulation (2007) 1.48
Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells. Cardiovasc Res (2007) 1.46
Enrichment of neonatal rat cardiomyocytes in primary culture facilitates long-term maintenance of contractility in vitro. Am J Physiol Cell Physiol (2012) 1.46
Important role of Nox4 type NADPH oxidase in angiogenic responses in human microvascular endothelial cells in vitro. Arterioscler Thromb Vasc Biol (2007) 1.43
First hand transplant procedure in Australia: outcome at 2 years. Med J Aust (2013) 1.40
Long-term persistence of tissue-engineered adipose flaps in a murine model to 1 year: an update. Plast Reconstr Surg (2009) 1.39
An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct. FASEB J (2006) 1.30
Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension (2007) 1.28
Differentiation of human adipose-derived stem cells into beating cardiomyocytes. J Cell Mol Med (2010) 1.27
Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation (2002) 1.27
Regulation of cell proliferation by NADPH oxidase-mediated signaling: potential roles in tissue repair, regenerative medicine and tissue engineering. Pharmacol Ther (2009) 1.22
Natural phenolic compounds as cardiovascular therapeutics: potential role of their antiinflammatory effects. Curr Vasc Pharmacol (2003) 1.18
Angiogenic growth factor synergism in a murine tissue engineering model of angiogenesis and adipogenesis. Am J Pathol (2007) 1.17
Mesenchymal stem cell durotaxis depends on substrate stiffness gradient strength. Biotechnol J (2013) 1.16
NADPH oxidase isoform selective regulation of endothelial cell proliferation and survival. Naunyn Schmiedebergs Arch Pharmacol (2009) 1.15
Age-related alterations in mesenchymal stem cells related to shift in differentiation from osteogenic to adipogenic potential: implication to age-associated bone diseases and defects. Mech Ageing Dev (2012) 1.13
Differentiation of human adipose-derived stem cells into fat involves reactive oxygen species and Forkhead box O1 mediated upregulation of antioxidant enzymes. Stem Cells Dev (2012) 1.12
Testosterone (T) enhances apoptosis-related damage in human vascular endothelial cells. Endocrinology (2002) 1.12
Stimulation of adipogenesis of adult adipose-derived stem cells using substrates that mimic the stiffness of adipose tissue. Biomaterials (2013) 1.11
Tissue engineering skin flaps: which vascular carrier, arteriovenous shunt loop or arteriovenous bundle, has more potential for angiogenesis and tissue generation? Plast Reconstr Surg (2003) 1.10
Hypoxic preconditioning enhances survival of human adipose-derived stem cells and conditions endothelial cells in vitro. Stem Cells Dev (2012) 1.08
Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression. Hypertension (2005) 1.08
Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits. Circ Res (2002) 1.07
Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I. Arterioscler Thromb Vasc Biol (2010) 1.06
Contact with existing adipose tissue is inductive for adipogenesis in matrigel. Tissue Eng (2006) 1.05
In situ mechanotransduction via vinculin regulates stem cell differentiation. Stem Cells (2013) 1.05
Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo. Atherosclerosis (2007) 1.05
Adipose tissue engineering based on the controlled release of fibroblast growth factor-2 in a collagen matrix. Tissue Eng (2006) 1.05
Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology. Clin Exp Pharmacol Physiol (2003) 1.04
New murine model of spontaneous autologous tissue engineering, combining an arteriovenous pedicle with matrix materials. Plast Reconstr Surg (2004) 1.04
Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP. Cardiovasc Res (2003) 1.03
Engineering cardiac tissue in vivo from human adipose-derived stem cells. Biomaterials (2010) 1.02
Adipose differentiation of bone marrow-derived mesenchymal stem cells using Pluronic F-127 hydrogel in vitro. Biomaterials (2007) 1.01
Adipose-derived stem cells promote angiogenesis and tissue formation for in vivo tissue engineering. Tissue Eng Part A (2013) 1.01
Increasing the volume of vascularized tissue formation in engineered constructs: an experimental study in rats. Plast Reconstr Surg (2003) 1.01
Altered epithelial cell proportions in the fetal lung of glucocorticoid receptor null mice. Am J Respir Cell Mol Biol (2003) 1.00
Vascularized tissue engineering mouse chamber model supports thymopoiesis of ectopic thymus tissue grafts. Tissue Eng Part C Methods (2010) 1.00
Translation-linked mRNA destabilization accompanying serum-induced Nox4 expression in human endothelial cells. Antioxid Redox Signal (2009) 0.99
Early increase of Nox4 NADPH oxidase and superoxide generation following endothelin-1-induced stroke in conscious rats. J Neurosci Res (2008) 0.98
NADPH-oxidase activity is elevated in penumbral and non-ischemic cerebral arteries following stroke. Brain Res (2006) 0.98
Superoxide dismutase mimetic M40403 improves endothelial function in apolipoprotein(E)-deficient mice. Br J Pharmacol (2003) 0.97
Hypoxic conditioning enhances the angiogenic paracrine activity of human adipose-derived stem cells. Stem Cells Dev (2013) 0.96
Generation of a vascularized organoid using skeletal muscle as the inductive source. FASEB J (2005) 0.96
Suppression of oxidative stress in the endothelium and vascular wall. Endothelium (2004) 0.94
Trichostatin A enhances differentiation of human induced pluripotent stem cells to cardiogenic cells for cardiac tissue engineering. Stem Cells Transl Med (2013) 0.94
Survival and differentiation of pituitary colony-forming cells in vivo. Stem Cells (2007) 0.93
Tympanic membrane repair using silk fibroin and acellular collagen scaffolds. Laryngoscope (2013) 0.93
Monocyte chemoattractant protein-1 and nitric oxide promote adipogenesis in a model that mimics obesity. Obesity (Silver Spring) (2007) 0.92
Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes. J Clin Endocrinol Metab (2007) 0.92
B-type natriuretic peptide prevents acute hypertrophic responses in the diabetic rat heart: importance of cyclic GMP. Diabetes (2003) 0.91
Skin graft failure is predicted by waist-hip ratio: a marker for metabolic syndrome. ANZ J Surg (2007) 0.91
Nox4 modulates collagen production stimulated by transforming growth factor β1 in vivo and in vitro. Biochem Biophys Res Commun (2012) 0.91
Seeding of pancreatic islets into prevascularized tissue engineering chambers. Tissue Eng Part A (2009) 0.91
Retrograde axonal tracing using manganese enhanced magnetic resonance imaging. Neuroimage (2010) 0.90
Post-traumatic pseudolipomas--a review and postulated mechanisms of their development. J Plast Reconstr Aesthet Surg (2009) 0.90
Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation. Circulation (2003) 0.90
Adventitial application of the NADPH oxidase inhibitor apocynin in vivo reduces neointima formation and endothelial dysfunction in rabbits. Cardiovasc Res (2007) 0.90
NADPH-induced contractions of mouse aorta do not involve NADPH oxidase: a role for P2X receptors. J Pharmacol Exp Ther (2006) 0.90
Prostacyclin signaling boosts NADPH oxidase 4 in the endothelium promoting cytoprotection and angiogenesis. Antioxid Redox Signal (2014) 0.89
Spontaneous large volume adipose tissue generation from a vascularized pedicled fat flap inside a chamber space. Tissue Eng (2007) 0.89
11Beta hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle. Clin Endocrinol (Oxf) (2006) 0.89
Implanted myoblast survival is dependent on the degree of vascularization in a novel delayed implantation/prevascularization tissue engineering model. Tissue Eng Part A (2010) 0.89
Tissue engineering of the tympanic membrane. Tissue Eng Part B Rev (2012) 0.89
Animal models of chronic tympanic membrane perforation: in response to plasminogen initiates and potentiates the healing of acute and chronic tympanic membrane perforations in mice. Clin Transl Med (2014) 0.89
Seat belt injury to the female breast: review and discussion of its surgical management. ANZ J Surg (2010) 0.89
Cardioprotective action of CRF peptide urocortin against simulated ischemia in adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol (2002) 0.88
Prefabricated engineered skin flap using an arteriovenous vascular bundle as a vascular carrier in rabbits. Plast Reconstr Surg (2006) 0.88
Glial cell line-derived neurotrophic factor gene transfer exerts protective effect on axons in sciatic nerve following constriction-induced peripheral nerve injury. Hum Gene Ther (2011) 0.88
Endogenous estrogen deficiency reduces proliferation and enhances apoptosis-related death in vascular smooth muscle cells: insights from the aromatase-knockout mouse. Circulation (2004) 0.88
Prostacyclin receptor suppresses cardiac fibrosis: role of CREB phosphorylation. J Mol Cell Cardiol (2010) 0.88
Reconstituted high-density lipoprotein suppresses leukocyte NADPH oxidase activation by disrupting lipid rafts. Free Radic Res (2009) 0.87
Molecular aspects of tissue engineering in the dental field. Periodontol 2000 (2006) 0.87
Ischemic preconditioning promotes intrinsic vascularization and enhances survival of implanted cells in an in vivo tissue engineering model. Tissue Eng Part A (2012) 0.86
CYT997: a novel orally active tubulin polymerization inhibitor with potent cytotoxic and vascular disrupting activity in vitro and in vivo. Mol Cancer Ther (2009) 0.86
Long-term stability of adipose tissue generated from a vascularized pedicled fat flap inside a chamber. Plast Reconstr Surg (2011) 0.86
Lower risk of postinfarct rupture in mouse heart overexpressing beta 2-adrenergic receptors: importance of collagen content. J Cardiovasc Pharmacol (2002) 0.86
Mast cells play a pivotal role in ischaemia reperfusion injury to skeletal muscles. Lab Invest (2004) 0.86
Differential effects of gemfibrozil on migration, proliferation and proteoglycan production in human vascular smooth muscle cells. Atherosclerosis (2002) 0.86
Systemic upregulation of NADPH oxidase in diet-induced obesity in rats. Redox Rep (2011) 0.86